Stockreport
What to Expect From Amgen's Next Quarterly Earnings Report [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
therapeutics for a wide range of diseases, including cancer, cardiovascular conditions, and autoimmune disorders. It markets leading medicines such as Enbrel, Prolia, and Repatha while collaborating with partners like AstraZeneca plc and UCB to expand its pipeline and global reach. The Thousand Oaks, California-based company is expected to release its fiscal Q1 2026 results after the market closes on Thursday, Apr. 30. Ahead of this event, analysts expect AMGN to report an adjusted EPS of $4.75, down 3.1% from $4.90 in the prior year's quarter. However, it has surpassed Wall Street's bottom-line estimates in the past four quarters. More News from Barchart Tesla Earnings, Hormuz and Other Key Things to Watch this Week Netflix Generates Massive FCF and FCF Margins - NFLX Price Targets Are Higher Profit Jumped 58% at Taiwan Semi. Does That Make TSM Stock a Buy Here? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, an
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular's Paratope-PLUS™ CDR-Scanning [Yahoo! Finance][Yahoo! Finance]
- Amgen (AMGN) was given a new $366.00 price target by Canaccord Genuity Group Inc..[MarketBeat]
- UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 [Yahoo! Finance][Yahoo! Finance]
- ISPE Announces Keynote Speakers for its First-Ever 2026 ISPE AI in Life Sciences Summit - Powered by GAMP® [Yahoo! Finance][Yahoo! Finance]
- ???????2035????589?????? ?????????????????????CAGR18.15%???? : ???????????????????? [CNET News][CNET News]
- More
AMGN
SEC Filings
SEC Filings
- 4/15/26 - Form DEFA14A
- 4/7/26 - Form DEFA14A
- 4/7/26 - Form DEF
- AMGN's page on the SEC website
- More